TipRanks
Advertisement
Advertisement

FR:IPH Stock Latest News

Innate Pharma Maps Pivotal Path in Earnings Call
Company AnnouncementsInnate Pharma Maps Pivotal Path in Earnings Call
10d ago
Innate Pharma Secures Sobi Partnership Cash and Extends Runway as Key Oncology Trials Advance
PremiumCompany Announcements
Innate Pharma Secures Sobi Partnership Cash and Extends Runway as Key Oncology Trials Advance
16d ago
Innate Pharma-Sobi Partnership Closes, Unlocks $75 Million and Phase 3 Lacutamab Trial
PremiumCompany Announcements
Innate Pharma-Sobi Partnership Closes, Unlocks $75 Million and Phase 3 Lacutamab Trial
16d ago
Innate Pharma says previously announced partnership with Sobi now effective
PremiumThe Fly
Innate Pharma says previously announced partnership with Sobi now effective
17d ago
IPHA
Innate Pharma to deliver H1 2026 business update via investor webcast
PremiumCompany Announcements
Innate Pharma to deliver H1 2026 business update via investor webcast
23d ago
Innate Pharma to Highlight Oncology Pipeline at H.C. Wainwright Investment Conference
PremiumCompany AnnouncementsInnate Pharma to Highlight Oncology Pipeline at H.C. Wainwright Investment Conference
1M ago
Innate Pharma to Spotlight Oncology Pipeline at H.C. Wainwright Investor Conference
Premium
Company Announcements
Innate Pharma to Spotlight Oncology Pipeline at H.C. Wainwright Investor Conference
1M ago
Innate Pharma Raises €30 Million in Private Share Placement to Fund Oncology Pipeline
Premium
Company Announcements
Innate Pharma Raises €30 Million in Private Share Placement to Fund Oncology Pipeline
1M ago
6K
Innate Pharma price target raised to $9 from $8 at BTIG
PremiumThe Fly
Innate Pharma price target raised to $9 from $8 at BTIG
2M ago
IPHA
Innate Pharma Schedules Investor Call as Oncology Pipeline Advances
PremiumCompany Announcements
Innate Pharma Schedules Investor Call as Oncology Pipeline Advances
2M ago
Innate Pharma Raises €30 Million in Share Offering to Extend Cash Runway
PremiumCompany Announcements
Innate Pharma Raises €30 Million in Share Offering to Extend Cash Runway
2M ago
Innate Pharma launches €22.5m share placement to fund ADC pipeline and extend runway
PremiumCompany Announcements
Innate Pharma launches €22.5m share placement to fund ADC pipeline and extend runway
2M ago
Leerink upgrades Innate Pharma to Outperform after lacutamab deal
PremiumThe FlyLeerink upgrades Innate Pharma to Outperform after lacutamab deal
2M ago
IPHA
Innate Pharma upgraded to Outperform from Market Perform at Leerink
Premium
The Fly
Innate Pharma upgraded to Outperform from Market Perform at Leerink
2M ago
IPHA
Innate Pharma price target raised to $7 from $5 at H.C. Wainwright
Premium
The Fly
Innate Pharma price target raised to $7 from $5 at H.C. Wainwright
2M ago
IPHA
Innate Pharma, Sobi to enable initiation of the TELLOMAK-3 study
PremiumThe Fly
Innate Pharma, Sobi to enable initiation of the TELLOMAK-3 study
2M ago
IPHA
Innate Pharma CMO Sonia Quaratino to depart, Markus Jensen to succeed
PremiumThe Fly
Innate Pharma CMO Sonia Quaratino to depart, Markus Jensen to succeed
2M ago
IPHA
Innate Pharma Secures Funding and Advances Lacutamab to Phase 3 With New CMO
PremiumCompany Announcements
Innate Pharma Secures Funding and Advances Lacutamab to Phase 3 With New CMO
2M ago
Innate Pharma CMO to Spotlight Cancer Pipeline at BTIG Bladder Cancer Panel
PremiumCompany Announcements
Innate Pharma CMO to Spotlight Cancer Pipeline at BTIG Bladder Cancer Panel
2M ago
Innate Pharma Completes Phase 1 Dose Escalation Enrollment for Nectin-4 ADC IPH4502
PremiumCompany AnnouncementsInnate Pharma Completes Phase 1 Dose Escalation Enrollment for Nectin-4 ADC IPH4502
2M ago
6K
Innate Pharma completes enrollment in dose escalation of IPH4502 study
Premium
The Fly
Innate Pharma completes enrollment in dose escalation of IPH4502 study
2M ago
IPHA
Innate Pharma Reports Voting Outcomes from 2026 Annual General Meeting
Premium
Company Announcements
Innate Pharma Reports Voting Outcomes from 2026 Annual General Meeting
4M ago
6K

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >